Curative Biotechnology Stock Alpha and Beta Analysis

CUBT Stock  USD 0.01  0.0001  1.14%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Curative Biotechnology. It also helps investors analyze the systematic and unsystematic risks associated with investing in Curative Biotechnology over a specified time horizon. Remember, high Curative Biotechnology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Curative Biotechnology's market risk premium analysis include:
Beta
2.3
Alpha
(0.19)
Risk
127.75
Sharpe Ratio
0.13
Expected Return
16.46
Please note that although Curative Biotechnology alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Curative Biotechnology did 0.19  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Curative Biotechnology stock's relative risk over its benchmark. Curative Biotechnology has a beta of 2.30  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Curative Biotechnology will likely underperform. Enterprise Value is likely to gain to about 17.1 M in 2024, whereas Book Value Per Share is likely to drop (0) in 2024.

Enterprise Value

17.12 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Curative Biotechnology Backtesting, Curative Biotechnology Valuation, Curative Biotechnology Correlation, Curative Biotechnology Hype Analysis, Curative Biotechnology Volatility, Curative Biotechnology History and analyze Curative Biotechnology Performance.
For more information on how to buy Curative Stock please use our How to Invest in Curative Biotechnology guide.

Curative Biotechnology Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Curative Biotechnology market risk premium is the additional return an investor will receive from holding Curative Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Curative Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Curative Biotechnology's performance over market.
α-0.19   β2.30

Curative Biotechnology expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Curative Biotechnology's Buy-and-hold return. Our buy-and-hold chart shows how Curative Biotechnology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Curative Biotechnology Market Price Analysis

Market price analysis indicators help investors to evaluate how Curative Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Curative Biotechnology shares will generate the highest return on investment. By understating and applying Curative Biotechnology stock market price indicators, traders can identify Curative Biotechnology position entry and exit signals to maximize returns.

Curative Biotechnology Return and Market Media

The median price of Curative Biotechnology for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 0.012 with a coefficient of variation of 26.65. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.01, and mean deviation of 0.0. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
10 Most Promising Biotech Stocks According to Hedge Funds - Insider Monkey
10/11/2024
2
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 - The Manila Times
11/19/2024

About Curative Biotechnology Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Curative or other stocks. Alpha measures the amount that position in Curative Biotechnology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Inventory Turnover0.220.21
ROIC2.192.29
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Curative Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Curative Biotechnology's short interest history, or implied volatility extrapolated from Curative Biotechnology options trading.

Build Portfolio with Curative Biotechnology

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Curative Stock Analysis

When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.